Rifampicin does not appear to be toxic to human enzymes (Wehrli, Nuesch, Knusel, and Staehelin, 1968) . The most recent experimental studies have shown that rifampicin inhibits the growth of certain pox-and adeno-viruses (Heller, Argaman, Levy, and Goldblum, 1969; Subak-Sharpe, Timbury, and Williams, 1969) . Furthermore, rifampicin is said to inhibit TRIc-agents (Becker and Zakay-Rones, 1969) distribution is uniform in all the body tissues; it is excreted via the bile by the same mechanism as bilirubin, and, to a lesser degree, via the kidneys. Rifampicin is normally well tolerated, and sideeffects such as dyspepsia and allergic complaints are extremely rare. Rifampicin is intensely red-brown in colour, and stains the urine reddish-orange. Among the contraindications are icterus with delayed bilirubin excretion, and pregnancy during the first trimester.
The effect of a single dose of 900 mg. rifampicin on acute gonococcal infections has already been reported. Willcox, Morrison, and Cobbold (1970) found a cure rate of 89 per cent. in a series of 89 cases in men; Ciaula and Rantuccio (1968) treated 32 patients, of whom 31 were cured with a single dose of rifampicin, and the other with two doses of 900 mg. administered at an interval of 1 week. Califano and Tagliavini (1968) achieved a recovery rate of 95 5 per cent. in a series of 96 patients. Rifampicin in this dosage does not appear to affect Treponema pallidum nor to mask syphilitic infections: In three cases of primary and two of secondary syphilis, the titre of the serological tests rose after treatment (Fuga, 1968) , and in a case reported by Arya, Rao, and Nnochiri (1971) a primary chancre developed 1 week after the administration of 900 mg. rifampicin and was dark-field positive 10 days after a second dose.
Present investigation MATERIAL AND METHODS
A series was examined of 118 consecutive patients (76 men and 42 women) with gonorrhoea, who attended for the first time on all the odd days of the trial period. Each patient was given a single oral dose of 900 mg. rifampicin immediately the diagnosis had been made on the basis of microscopic examination of a methylene-blue stained urethral smear in the cases of men, and of urethral and cervical smears in women. Cultures were performed in all cases, and determination of antibiotic sensitivities was performed on 75 isolates, some from the trial group and some from the controls. Table I shows that 36 women were followed up with three cultures and 62 men with two cultures at 1 week's interval after treatment. Twenty patients who failed to attend for follow-up examinations and four with negative results to cultures were excluded from the series. 78 were cured, six were considered to be re-infected, and in ten cases the treatment was considered to have failed. In these last cases, reinfection was discounted as the patients themselves denied such a possibility and the pattern of antibiotic sensitivities of the strains isolated before and after treatment remained similar. In the group with re-infections, the resistance patterns of the initial and post-treatment isolates showed differences, a finding which was confirmed by admission of reexposure to infection in all cases. One case of reinfection was cured by a further dose of rifampicin, four by standard penicillin-probenecid treatment, and one by tetracycline. In two cases in which the initial rifampicin treatment failed, re-treatment at the first follow-up examination was successful. In one case, the second rifampicin treatment failed, but the infection was cured with penicillin and probenecid, as were the remaining seven cases in which rifampicin treatment was not repeated.
In 41 cases, treatment response was related to the time of the last meal before treatment. Table II shows that there is no indication that the degree of gastric filling affects the result of that treatment at the dose used.
With regard to side-effects, there was only one case of vomiting after administration of the dose; (Phillips, Rimmer, Ridley, Lynn, and Warren, 1970) , and also to other antibiotics-spiramycin, streptomycin, tetracycline, and erythromycin (Reyn and Bentzon, 1969) . In the rre3ent series there was a correlation between the minimum inhibition concentrations for rifampicin and penicillin, but this was of very slight degree though statstically significant.
Discussion
In the treatment of acute gonorrhoea many alternatives to penicillin have been tried. An ideal antigonorrhoeal substance would have the following properties: it should be effective for single-session therapy, easy to administer, non-toxic, bactericidal but not treponemicidal, and non-allergic. Rifampicin seems to satisfy these criteria, although its 
